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ABSTRACT
....................................................................................................................................................
Objective To develop an efficient surveillance approach for childhood diabetes by type across 2 large US health care systems, using phenotyping
algorithms derived from electronic health record (EHR) data.
Materials and Methods Presumptive diabetes cases <20 years of age from 2 large independent health care systems were identified as those
having 1 of the 5 indicators in the past 3.5 years, including elevated HbA1c, elevated blood glucose, diabetes-related billing codes, patient prob-
lem list, and outpatient anti-diabetic medications. EHRs of all the presumptive cases were manually reviewed, and true diabetes status and diabe-
tes type were determined. Algorithms for identifying diabetes cases overall and classifying diabetes type were either prespecified or derived from
classification and regression tree analysis. Surveillance approach was developed based on the best algorithms identified.
Results We developed a stepwise surveillance approach using billing code–based prespecified algorithms and targeted manual EHR review, which
efficiently and accurately ascertained and classified diabetes cases by type, in both health care systems. The sensitivity and positive predictive val-
ues in both systems were approximately 90% for ascertaining diabetes cases overall and classifying cases with type 1 or type 2 diabetes. About
80% of the cases with “other” type were also correctly classified. This stepwise surveillance approach resulted in a >70% reduction in the num-
ber of cases requiring manual validation compared to traditional surveillance methods.
Conclusion EHR data may be used to establish an efficient approach for large-scale surveillance for childhood diabetes by type, although some
manual effort is still needed.
....................................................................................................................................................
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BACKGROUND AND SIGNIFICANCE
Large population-based registries, including the SEARCH for Diabetes
in Youth (SEARCH) study1 and others,2,3 have provided critical data for
surveillance of diabetes among US children and adolescents.
Increasing trends in the prevalence of both type 1 and type 2 diabetes
and in the incidence of type 1 diabetes have been documented.1,2,4–6
However, such surveillance systems are resource intensive and are
associated with considerable delays in reporting results.7 A more effi-
cient surveillance system is needed for sustained monitoring of the
incidence and prevalence of childhood diabetes, so as to inform health
care needs for this growing population.
Many US healthcare systems have transitioned to the use of elec-
tronic health records (EHRs).8 An EHR-based surveillance system has the
potential to substantially increase the quantity, breadth, and timeliness of
data available to health care systems and health departments, and could
be more efficient than traditional surveillance methods.9 However, few
US studies have reported EHR-derived algorithms and their performance
in youth with diabetes.10,11 No validation study has been done to assess
the generalizability of these algorithms. Little is known about the utility of
automated algorithms derived from EHR data for surveillance of childhood
diabetes within or across health care systems.
Previously, automated algorithms for surveillance were prespeci-
fied by manually manipulating the available EHR data elements.10,11
This approach does not maximize the potential of EHR data, and may
be the reason that algorithms to ascertain type 2 diabetes in youth
with reasonable sensitivity, specificity, and positive predictive value
(PPV) have yet to be found.10,11 The value of classification and regres-
sion tree (CART) analysis in public health research has been recog-
nized and emphasized, but infrequently used.12 The CART method
makes no assumptions about the variable distributions or relationships
and generates a graphical prediction tree of classification that is easy
to visualize.13 Therefore, CART analysis may be a useful tool for elec-
tronically deriving algorithms for surveillance of diabetes in youth, in
particular a type 2 diabetes algorithm.
OBJECTIVES
The objectives of this study were to: (i) determine if CART analysis
yields EHR algorithms with reasonable sensitivity, specificity, and PPV
for surveillance of childhood diabetes overall and by diabetes type
compared to the prespecified simple algorithms; (ii) determine
whether algorithms derived from one health care system have compa-
rable performance in another independent health care system; (iii) as-
sess whether algorithm performance differs by age or race; and (iv)
develop an efficient approach for sustainable surveillance of childhood
diabetes incorporating use of the derived EHR algorithms that would
substantially reduce the need for review of individual medical records.
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MATERIALS AND METHODS
We used EHR data from the Medical University of South Carolina (MUSC)
and the University of North Carolina Health Care System (UNC). The cur-
rent study was designed to specifically address surveillance of prevalent
diabetes cases in youth receiving care within the healthcare systems.
Preliminary results related to EHR data from UNC have been published.10
Description of 2 health care systems and data sources
MUSC and UNC are large not-for-profit integrated academic health
care systems located in Charleston, South Carolina, and central North
Carolina, respectively. They both provide health care for a broad range
of patients, including those without insurance. MUSC is a 700-bed re-
ferral and teaching facility, providing care for over 250 000 patients
annually. With a central 800-bed tertiary care center, and through its
network of primary care and specialty physician practices located in 5
counties, UNC cares for over 800 000 patients annually. This study
was approved by the Institutional Review Boards at MUSC and UNC.
During the data collection period, MUSC used the Epic EHR system
and UNC used a locally developed EHR system. EHR data in both health
care systems included demographics, outpatient medication lists for
prescriptions, a variety of notes entered by health care professionals,
and laboratory test results. International Classification of Diseases,
Ninth Revision, Clinical Modification (ICD-9-CM) codes were used at
both locations for health services billing (ie, billing data). At MUSC, bill-
ing data were incorporated into the EHRs, patient problem lists were
not available, and medication data were not available until May 2012.
At UNC, billing data were maintained and updated separately from the
EHRs. “Full data” in this study were the data elements available in both
health care systems, including billing data, outpatient anti-diabetes
medication data, laboratory test results, and demographics.
Case identification and validation
The study population at MUSC included all children <20 years of age
as of December 31, 2012, who were seen by a health care provider at
least once for any reason between July 1, 2012, and December 31,
2012. At UNC, we included all children <20 years of age as of
December 31, 2011, who were seen by a health care provider at least
once for any reason in 2011.
The initial criteria used to identify presumptive diabetes cases from
the study population at both health care systems were: (i) 1 HbA1c
 6.0% (42 mmol/mol); or (ii) 2 random blood glucose 200 mg/dL
on different days or 1 fasting blood glucose 126 mg/dL; or (iii) 1
patient problem list diabetes-related ICD-9-CM codes; or (iv) 1 billing
data diabetes-related ICD-9-CM codes; or (v) 1 outpatient anti-diabetes
medications, including insulin, glucagon, metformin, sulfonylurea, gluca-
gon-like peptide-1 receptor agonists, thiazolidinediones, and other hypo-
glycemic agents.10 The following diabetes-related ICD-9-CM codes were
used: 250.xx (diabetes mellitus), 775.1 (neonatal diabetes), 648.0x
(diabetes in pregnancy, non-gestational), 357.2 (diabetic neuropathy),
362.0x (diabetic retinopathy), and 366.41 (diabetic cataract). We searched
EHR data from July 1, 2009, to December 31, 2012, at MUSC, and from
July 1, 2008, to December 31, 2011, at UNC for these 5 diabetes criteria.
Patients meeting any of the 5 criteria were identified as presumptive dia-
betes cases. The definition of presumptive diabetes cases was designed
to be highly sensitive and thus children not identified as presumptive
cases were assumed to not have diabetes (ie, true negatives).
True diabetes status and type were determined by the presence of
a diabetes diagnosis in the EHR in 1 or more notes written by health
care providers (gold standard), which is consistent with the SEARCH
case validation protocol.14 Reviewers at each of the 2 health care sys-
tems were trained using the SEARCH standardized protocol by a
member of the SEARCH team (J.T.), who has over 10 years of experi-
ence with the SEARCH case ascertainment protocol. More details of
the case validation processes can be found elsewhere.10
Criteria for evaluating algorithms’ performance
Attributes critical for a disease surveillance system recommended by
the Centers for Disease Control and Prevention include simplicity, time-
liness, high sensitivity, and high PPV.15 High sensitivity is crucial for
identifying most of the diabetes cases. High PPV is preferred in order to
reduce the number of false positives. For surveillance of childhood dia-
betes, high specificity is important for differentiating between diabetes
types and also critical to yield high PPV. A promising algorithm for sur-
veillance should yield a sensitivity, specificity, and PPV 90%.10 In this
report, specificity was only shown in the results when evaluating the
type 1 and type 2 algorithms in true diabetes cases, because we aimed
to conduct population surveillance so specificity would be consistently
>90% due to the low prevalence of diabetes in children.
Statistical Analysis
The characteristics of the study population, presumptive cases and
true cases, were described. We evaluated the performance of the pre-
specified algorithms for identifying diabetes cases regardless of type,
then by type 1 or type 2 diabetes cases in both health care systems.
Those pre-specified algorithms were created based on clinical knowl-
edge and were previously published.10 Next, we assessed the perfor-
mance of CART algorithms within and between health care systems.
Specifically, we performed CART analysis on the data from MUSC
(training dataset) and then applied the derived algorithms from the
training dataset to UNC data (validation dataset) and vice versa. The
CART analysis recursively identified classifiers that efficiently seg-
mented the sample into mutually exclusive subgroups (eg, diabetes
and not diabetes, or type 1 and type 2 diabetes).13 There was a com-
plexity parameter tuned by a 10-fold cross-validation procedure to
control the depth of the generated tree (ie, to avoid over-fitting). We
searched over a prespecified finite set of complexity levels to select
the best complexity parameter that minimized the cross-validation er-
ror. This parameter was used to replicate the same prediction tree
(ie, derived algorithm) from the training dataset in the validation data-
set. The variables used for CART analysis were coded and processed
identically between the 2 health care systems (Appendix, Table 1).
The performance of the algorithms for identifying diabetes cases
regardless of type was evaluated within the total study population. The
performance of type 1 or type 2 algorithms was evaluated within the
true cases.10,11 We also evaluated whether algorithm performance dif-
fered by age (<10 years versus 10–19 years) or race (white versus
non-white). Only 2.3% of the total type 2 cases were <10 years of
age, so the performance was not calculated for this younger group.
Finally, a stepwise surveillance approach was developed with the
goal of improving efficiency of the process by employing the top-
performing algorithms in order to minimize the manual validation
efforts and maintain accuracy. The top-performing diabetes type–
specific algorithms used for this approach should have 90% sensi-
tivity, specificity, and PPV.10 In practice, our approach would assume
that the individuals ascertained by the best top-performing type 1 or
type 2 algorithm were true type 1 or type 2 cases, respectively, with-
out manual validation of each case against medical records. For the
remaining cases who were not selected by the best algorithms, man-
ual medical record review would be conducted. To evaluate this
approach, we considered sensitivity and PPV based on the gold stan-
dard. Also, the number and percentage of medical records that
required manual review were calculated as a marker of efficiency.
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CART analysis was performed using the rpart package and R sta-
tistical software package, version 3.0.2.16 Other analyses were per-
formed using SAS version 9.3 (SAS Institute, Cary, NC, USA).
RESULTS
At MUSC, we identified 1055 presumptive cases from 43 511 children
<20 years of age with at least 1 health care visit between July 1 and
December 31, 2012 (Table 1). Based on the manual medical record
review of presumptive cases (gold standard), 660 (62.6%) true cases
(483 type 1, 129 type 2, and 48 other types) were ascertained. At
UNC, the initial algorithm identified 1289 presumptive diabetes cases
from 57 767 children <20 years of age with at least 1 health care visit
in 2011.10 Of those, 537 (41.7%) were true cases (405 type 1, 86
type 2, and 46 other diabetes types).
Performance of the prespecified algorithms in 2 health care
systems
Identifying diabetes cases regardless of diabetes type
Billing data had similar performance overall and within age or racial sub-
groups between the 2 health care systems (Appendix, Tables 2 and 3).
The sensitivity and PPV of billing data were 97.9% and 81.6%, respec-
tively, in MUSC and were 97.0% and 82.2%, respectively, in UNC.10
Outpatient medications at MUSC had a low sensitivity of 12.7%, com-
pared to a sensitivity of 88.5% at UNC. The algorithm in which 2 crite-
ria were met approximately satisfied our prespecified 90% criteria in
both health care systems. The algorithm in which 1 criteria were met
had poor PPV in both systems (62.6% and 41.7% at MUSC and UNC, re-
spectively). Among age and racial subgroups, in both systems, the PPV
of the glucose criterion or billing data was much lower in youth <10
Table 1: Demographic and clinical characteristics of the total study population, presumptive diabetes cases, and true diabetes cases at
MUSC in 2012 and at UNC in 2011
Characteristics Study population Presumptive casesa True diabetes cases Type 1 cases Type 2 cases Other casesb
MUSC UNCc MUSC UNC c MUSC UNC c MUSC UNC c MUSC UNC c MUSC UNCc
All, n 43 511 57 767 1055 1289 660 537 483 405 129 86 48 46
Female, % 51.5 48.1 52.3 52.7 52.7 55.7 48.0 54.8 72.9 60.5 45.8 54.3
Age (years)d, %
0–4.9 35.3 36.3 11.4 26.9 2.3 2.8 2.9 3.2 0 0 2.1 4.3
5.0–9.9 24.8 22.2 13.7 12.1 13.5 12.5 16.6 15.6 2.3 2.3 12.5 4.3
10.0–14.9 20.8 19.8 34.1 24.0 37.3 32.6 39.5 34.6 32.6 34.9 27.1 10.9
15.0–17.9 12.1 12.7 26.1 22.0 31.2 30.2 27.7 26.4 41.1 37.2 39.6 50.0
18.0–19.9 7.1 9.0 14.7 15.0 15.8 22.0 13.3 20.3 24.0 25.6 18.8 30.4
Mean age,
years (SD)
8.0 (5.9) 8.6 (6.2) 12.3 (5.1) 11.0 (6.5) 13.6 (3.9) 14.4 (4.1) 13.1 (4.0) 13.9 (4.3) 15.2 (2.7) 15.8 (2.6) 14.1 (3.8) 16.0 (3.7)
Age at diagnosis,
years (SD)
9.3 (4.3) 8.8 (4.6) 8.0 (4.0) 7.9 (4.3) 13.0 (2.7) 12.9 (2.3) 12.2 (3.9) 12.8 (5.3)
Racee, %
White 49.3 48.5 51.7 53.0 59.6 61.6 72.7 67.9 13.2 32.6 52.1 60.9
Black 37.0 21.0 42.7 29.0 35.8 25.5 22.2 19.8 83.7 50.0 43.8 30.4
Other/unknown/
missing
13.7 30.5 5.7 18.0 4.7 12.9 5.2 12.3 3.1 17.4 4.2 8.7
Health insurance
type, %
Private 39.2 43.2 40.0 40.1 48.2 50.8 57.8 55.3 21.7 27.9 22.9 54.3
Government 52.5 42.4 48.0 47.6 38.8 34.1 29.4 29.1 66.7 57.0 58.3 34.8
Tricaref 5.0 8.3 4.1 9.1 4.9 11.0 5.4 12.1 1.6 5.8 8.3 10.9
Not insured/
missing/other
3.4 6.2 8.0 3.3 8.2 4.1 7.5 3.5 10.1 9.3 10.4 0
Abbreviations: MUSC: Medical University of South Carolina; SD: standard deviation; UNC: University of North Carolina.
aPresumptive cases were individuals with 1 of these criteria: 1 HbA1c  6.0% (42 mmol/mol); or 2 random blood glucose  200 mg/dL on
different days; or 1 fasting blood glucose 126 mg/dL; or 1 patient problem list diabetes-related ICD-9-CM codes; or 1 billing data diabe-
tes-related ICD-9-CM codes; or 1 diabetes-related outpatient medications, including insulin, glucagon, metformin, sulfonylurea, glucagon-like
peptide-1 receptor agonists, thiazolidinediones, and other hypoglycemic agents.
bAt MUSC: “Other” cases included 6 cases of maturity onset diabetes of the young (MODY) and 42 secondary diabetes cases, mostly steroid in-
duced or CF-related. At UNC: “Other” cases included 25 secondary diabetes cases, 2 MODY cases, and 19 diabetes type-unspecified cases.
cThe UNC data were previously published,10 but the presumptive cases here did not include those captured by inpatient medications.
dAt MUSC: Age was calculated as of December 31, 2012. At UNC: Age was calculated as of December 31, 2011.j
eEthnicity data were missing for about 98% of the patients at MUSC, so we were only able to categorize race.
fMilitary health insurance plan.
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years of age than in the older youth. HbA1c had higher PPV among
white youth than youth with non-white racial backgrounds.
Type 1 algorithms
All type 1 algorithms performed very similarly between the 2 health
care systems (Table 2). The 2 best type 1 algorithms were the ratio of
type 1 codes to the sum of type 1 and type 2 codes 0.5 or 0.6.
When the ratio was 0.6, the sensitivity, specificity, and PPV were
97.7%, 94.9%, and 98.1%, respectively, at MUSC, and 93.3%,
96.2%, and 98.7%, respectively, at UNC. Age and racial differences
were small, except that the specificity of these best 2 algorithms was
<90% in youth <10 years of age and in white youth (Table 3).
Type 2 algorithms
For both health care systems, none of the type 2 algorithms evaluated
had a sensitivity, specificity, and PPV approaching 90%; the highest
PPV was 75.5% (Table 2). The ratio of type 2 codes to the sum of type
1 and type 2 codes 0.4 or 0.5 or 0.6 had similar performance within
the health care systems, although the PPV was higher at MUSC than
at UNC. The PPV was considerably higher among youth with non-white
racial backgrounds in both health care systems (Table 3). Among the
non-white subgroup, the sensitivity, specificity, and PPV of the ratio of
type 2 codes to the sum of type 1 and type 2 codes 0.6 were
89.3%, 87.7%, and 84.0%, respectively, at MUSC, and 89.7%,
91.2%, and 80.0%, respectively, at UNC.
Performance of CART algorithms in 2 health care systems
Using billing data only
For algorithms used for identifying diabetes cases regardless of type,
most CART algorithms were close to the prespecified 90% criteria and
the algorithms had similar performance between health care systems.
Only small differences were observed between age and racial sub-
groups (Appendix, Table 4). Type 1 algorithms derived from CART
analysis were not superior to the prespecified type 1 algorithms. The
performance of type 2 algorithms was also not improved by using the
CART method relative to the prespecified method.
Using full data
The billing data only based algorithms for identifying diabetes cases
without regard to type, and type 1 algorithms were not improved upon
by adding additional data elements. For type 2 algorithms, use of full
data compared to use of billing data alone improved PPV from 58.3%
to 80.6% and decreased sensitivity from 93.1% to 80.1% at UNC; use
of full data improved PPV from 70.3% to 81.9% and decreased sensi-
tivity from 96.0% to 91.4% at MUSC. The type 2 algorithm had a sen-
sitivity of 91.4%, specificity of 95.1%, and PPV of 81.9% at MUSC
(Appendix, Figure 1; results in Appendix, Table 4) and had a sensitivity
of 80.1%, specificity of 96.3%, and PPV of 80.6% at UNC (Appendix,
Figure 2; results in Appendix, Table 4).
A stepwise surveillance approach
An identical stepwise surveillance approach was used in both health
care systems, which began with identifying presumptive cases (Figures
1A and 1B). The steps were: (i) applying 1 billing codes; (ii) applying
the best prespecified type 1 algorithm (ie, the ratio of type 1 codes to
the sum of type 1 and type 2 codes 0.6); the following step was orig-
inally designed to apply the best type 2 algorithm with 90% sensitiv-
ity, specificity, and PPV, but neither CART nor the prespecified type 2
algorithm met the 90% criterion; (iii) reviewing the medical records of
the remaining cases that were not classified by the previous steps; and
(iv) evaluating the performance of the stepwise surveillance approach.
Using this approach, 289 (27.4%) of the 1055 medical records at
MUSC (Table 4) and 234 (18.2%) of the 1289 records at UNC required
manual review. The sensitivity and PPV were close to or greater than
95% for identifying total diabetes cases and type 1 cases in both
health care systems. For type 2 diabetes, the sensitivity was approxi-
mately 90% in both systems and PPV was 100.0%. This approach
also classified cases of other diabetes types with a sensitivity of nearly
80% and PPV of 100%.
DISCUSSION
In both health care systems, we found that using billing data alone in
the prespecified algorithms was the most efficient for diabetes case
identification overall and for type 1 case classification. Billing data–
based prespecified type 1 algorithms met our criteria for surveillance,
and additional data including medication and laboratory data did not
improve the prespecified type 1 algorithms. CART type 1 algorithms
were not superior to the prespecified type 1 algorithms. For type 2 dia-
betes identification, the additional EHR data provided only a small im-
provement. However, neither CART nor the prespecified type 2
algorithms reached our 90% criteria for surveillance. We developed a
stepwise surveillance approach using a combination of billing data–
based prespecified algorithms and targeted manual review of EHRs
that ascertained and classified diabetes cases efficiently and accu-
rately in both health care systems. This stepwise approach required
much less manual effort (>70% reduction in EHR review) compared
to traditional methods. The performance of the stepwise surveillance
approach, billing data, and prespecified type 1 algorithms was similar
between the 2 health care systems.
The stepwise surveillance approach proposed in this study ascer-
tained and classified diabetes cases in youth accurately, with approxi-
mately 90% or higher sensitivity and PPV for total diabetes cases, type
1 and type 2 cases; and efficiently, with a reduction of >70% in the
number of cases requiring manual medical record review. Recent re-
ports suggest that other types of diabetes, including drug-induced dia-
betes and monogenic diabetes, are important components of
childhood diabetes.17,18 Together with the increasing prevalence of
type 2 diabetes,1 they have altered the pediatric diabetes landscape.
The stepwise surveillance approach also correctly classified most
cases with other diabetes types (80%) in both health care systems.
Billing data was the most important source of data for surveillance
with little gain from using additional EHR data. The sensitivity of billing
data for ascertaining diabetes overall was 97%. Also, billing data–
based prespecified type 1 algorithms performed very well in both
health care systems. For type 2 case classification, we previously
found that adding medication data improved the PPV of the prespeci-
fied type 2 algorithm, but the overall performance was not greatly im-
proved.10 Dart et al.19 also reported that the addition of medication
data did not substantially improve diabetes case identification, but
their study was unable to differentiate diabetes types. In the current
study, we employed CART analysis in an attempt to improve type 2
case classification. Within the health care systems, among total true
cases, the type 2 algorithm was improved slightly, but it was still not
sufficient for surveillance purposes.
Previous studies have identified the greater difficulty in classifying
type 2 cases in youth.10,11,20,21 At the current state of EHR develop-
ment and use of the ICD-9-CM coding system, together with the very
low prevalence of type 2 diabetes in youth,1 relying solely on an auto-
mated algorithm for type 2 case classification may not be possible.
First, ICD-9-CM type 2 codes include “unspecified” diabetes (250.X0
or 250.X2 with X¼ 0–9), which has very poor accuracy (<20%) for
classifying type 2 cases in children.21 A study found that few
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“unspecified” diabetes codes were assigned by use of ICD-10-CM.22
However, more investigation is needed to determine the utility of ICD-
10-CM codes for surveillance. Second, patients without diabetes may
still be incorrectly assigned a type 2 code if they have cystic fibrosis–
related diabetes, diabetes insipidus, or diabetes risk factors including
insulin resistance, obesity, impaired glucose tolerance, etc.21 Third,
type 2 codes may be misused for other forms of diabetes with less fa-
miliar codes, for example, steroid-induced diabetes (251.8 and
E932.0). In our study, the type 2 algorithms which identified most type
2 cases also identified most cases with drug-induced diabetes cases
(data not shown). Fourth, in some patients, a clinical differentiation be-
tween type 1 and type 2 diabetes is difficult at presentation with dia-
betes in children,23 if auto-antibodies and/or insulin sensitivity are not
measured.24 Fifth, insulin is commonly used in children with type 2 di-
abetes,25 which limits the use of medication as an efficient type clas-
sifier, though we did see small improvement with the inclusion of
medication data for type 2 algorithms in CART analysis. Finally, coders
at hospitals or practices may use “unspecified” type 2 codes if diag-
noses are indicated as “diabetes” on the billing form.21 Consequently,
manual review of medical records may be necessary to classify type 2
cases accurately.It is critical to establish generalizability before a sur-
veillance approach can be reliably implemented across health care
systems. Our analyses indicated quite good agreement between 2
large independent health care systems. First, the proposed surveil-
lance approach resulted in similar performance for estimating the
number of total diabetes cases, type 1, type 2, and other types of
Table 2: Performance of the prespecified type 1 and type 2 algorithms by age applied to all true cases at MUSC and UNCa
Non-CART Diabetes Algorithms System Met Criteria (N) Sensitivity (%) Specificity (%) PPV (%)
Total <10 y 10 y Total <10 y 10 y Total <10 y 10 y Total <10 y 10 y
Type 1 Algorithms
1 type 1 codes MUSC 570 97 473 99.0 100.0 98.7 48.0 70.0 46.7 83.9 96.9 81.2
UNC 443 76 367 97.0 98.7 96.7 62.1 83.3 61.1 88.7 98.7 86.6
2 type 1 codes MUSC 537 94 443 96.7 97.9 96.4 60.5 80.0 59.3 87.0 97.9 84.7
UNC 415 76 339 93.6 98.7 92.4 72.7 83.3 72.2 91.3 98.7 89.7
0 type 2 codes and 1
type 1 codes
MUSC 195 50 145 39.8 53.2 36.5 98.3 100.0 98.2 98.5 100.0 97.9
UNC 141 18 123 34.6 23.7 37.1 99.2 100.0 99.2 99.3 100.0 99.2
Ratio of type 1 codes to the sum
of type 1 and type 2 codes  0.3
MUSC 510 96 414 98.8 98.9 98.7 81.4 70.0 82.0 93.5 96.9 92.8
UNC 413 76 337 96.8 98.7 96.4 84.1 83.3 84.1 94.9 98.7 94.1
Ratio of type 1 codes to the sum
of type 1 and type 2 codes  0.4
MUSC 496 95 401 98.6 98.9 98.5 88.7 80.0 89.2 96.0 97.9 95.5
UNC 402 76 326 96.3 98.7 95.7 90.9 83.3 91.3 97.0 98.7 96.6
Ratio of type 1 codes to the sum of
type 1 and type 2 codes  0.5
MUSC 490 95 395 98.6 98.9 98.5 92.1 80.0 92.8 97.1 97.9 97.0
UNC 397 76 321 95.6 98.7 94.8 92.4 83.3 92.9 97.5 98.7 97.2
Ratio of type 1 codes to the sum of
type 1 and type 2 codes  0.6
MUSC 481 95 386 97.7 98.9 97.4 94.9 80.0 95.8 98.1 97.9 98.2
UNC 383 75 308 93.3 97.4 92.4 96.2 83.3 96.8 98.7 98.7 98.7
Type 2 Algorithms
1 type 2 codes MUSC 451 50 401 93.0 N/A 94.4 37.7 N/A 34.4 26.6 N/A 29.7
UNC 375 62 313 91.9 N/A 92.9 34.4 N/A 36.7 21.1 N/A 24.9
2 type 2 codes MUSC 316 33 283 83.7 N/A 85.7 60.8 N/A 59.3 34.2 N/A 38.2
UNC 256 31 225 82.6 N/A 83.3 59.0 N/A 58.2 27.7 N/A 31.0
1 type 2 codes and 0 type 1 codes MUSC 76 3 73 41.9 N/A 42.1 95.9 N/A 95.3 71.1 N/A 72.6
UNC 73 4 69 54.7 N/A 54.8 94.2 N/A 93.8 64.4 N/A 66.7
Ratio of type 2 codes to the sum of
type 1 and type 2 codes  0.3
MUSC 181 8 173 93.0 N/A 94.4 88.5 N/A 87.4 66.3 N/A 68.8
UNC 151 10 141 91.9 N/A 92.9 84.0 N/A 83.0 52.3 N/A 55.3
Ratio of type 2 codes to the sum of
type 1 and type 2 codes  0.4
MUSC 168 7 161 91.5 N/A 92.9 90.6 N/A 89.8 70.2 N/A 72.7
UNC 138 6 132 91.9 N/A 92.9 86.9 N/A 85.4 57.2 N/A 59.1
Ratio of type 2 codes to the sum of
type 1 and type 2 codes  0.5
MUSC 164 5 159 91.5 N/A 92.9 91.3 N/A 90.2 72.0 N/A 73.6
UNC 128 4 124 88.4 N/A 89.3 88.5 N/A 86.8 59.4 N/A 60.5
Ratio of type 2 codes to the sum of
type 1 and type 2 codes  0.6
MUSC 151 5 146 88.4 N/A 89.7 93.0 N/A 92.3 75.5 N/A 77.4
UNC 116 4 112 84.9 N/A 85.7 90.5 N/A 89.2 62.9 N/A 64.3
True diabetes cases (N¼ 660 at MUSC and N¼ 537 at UNC) confirmed by medical record review established our “gold standard” for evaluation of the algorithms’ performance.
Abbreviations: MUSC: Medical University of South Carolina; PPV: positive predictive value; UNC: University of North Carolina; y, years.
aResults from UNC were previously published.10
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diabetes cases, in both health care systems using identical prespeci-
fied algorithms in each step. Second, billing data had comparable per-
formance in both health care systems and billing data alone may help
to establish an efficient surveillance system. Additionally, billing data
are commonly available in health care systems. However, the 2 health
care systems compared here covered similar youth populations in
terms of age, gender, and insurance status, and were also similar in
terms of type and amount of data captured and organization of health
care delivery. It is not clear whether our stepwise approach will per-
form similarly in different types of health care systems, such as inte-
grated managed health care systems or the Indian Health Service.
Algorithms derived from CART analysis did not outperform the pre-
specified algorithms. This does not imply that CART analysis is not a
useful tool. CART analysis has value in classifying other health prob-
lems.26–28 In the context of childhood diabetes, limitations were en-
countered in the application of CART analysis, including limitations of
the ICD-9-CM coding system, miscoding issues, overlap in treatment
as described above, and incomplete data in the EHRs. Of note, CART
analysis yielded more complicated algorithms and captured interac-
tions that were hard to explain, leading to poor generalizability.
Limitations of this study should be noted. First, both health care
systems are public academic health care delivery systems. In both
systems, the EHR systems are evolving and imperfect. This character-
istic is, in a sense, also a strength of our study in that we sought to
evaluate our approach in the real world. Second, we assumed that in-
dividuals who were not captured by the initial 5 criteria for identifying
Table 3: Performance of the prespecified type 1 and type 2 algorithms by race applied to all true cases at MUSC and UNCa
Non-CART Diabetes Algorithms System Met Criteria (N) Sensitivity (%) Specificity (%) PPV (%)
Total white Other Total White Other Total white Other Total white Other
Type 1 Algorithms
1 type 1 codes MUSC 570 366 204 99.0 99.4 97.7 48.0 59.5 44.4 83.9 95.4 63.2
UNC 443 288 155 97.0 97.1 96.9 62.1 62.5 61.8 88.7 92.7 81.3
2 type 1 codes MUSC 537 355 182 96.7 96.6 97.0 60.5 61.9 60.0 87.0 95.5 70.3
UNC 415 276 139 93.6 94.2 92.3 72.7 69.6 75.0 91.3 93.8 86.3
0 type 2 codes and 1 type 1 codes MUSC 195 152 4 39.8 43.0 31.1 98.3 97.6 98.5 98.5 99.3 95.3
UNC 141 103 38 34.6 37.1 29.2 99.2 98.2 100.0 99.3 99.0 100.0
Ratio of type 1 codes to the sum of
type 1 and type 2 codes  0.3
MUSC 510 358 152 98.8 99.1 97.7 81.4 76.2 83.0 93.5 97.2 84.9
UNC 413 277 136 96.8 96.7 96.9 84.1 80.4 86.8 94.9 96.0 92.6
Ratio of type 1 codes to the sum of
type 1 and type 2 codes  0.4
MUSC 496 357 139 98.6 99.1 97.0 88.7 78.6 91.9 96.0 97.5 92.1
UNC 402 273 129 96.3 96.7 95.4 90.9 87.5 93.4 97.0 97.4 96.1
Ratio of type 1 codes to the sum of
type 1 and type 2 codes  0.5
MUSC 490 355 135 98.6 99.1 97.0 92.1 83.3 94.8 97.1 98.0 94.8
UNC 397 269 128 95.6 96.0 94.6 92.4 91.1 93.4 97.5 98.1 96.1
Ratio of type 1 codes to the sum of
type 1 and type 2 codes  0.6
MUSC 481 350 131 97.7 98.3 96.2 94.9 88.1 97.0 98.1 98.6 96.9
UNC 383 262 121 93.3 93.8 92.3 96.2 92.9 98.7 98.7 98.5 99.2
Type 2 Algorithms
1 type 2 codes MUSC 451 237 214 93.0 94.1 92.9 37.7 41.2 29.0 26.6 6.8 48.6
UNC 375 219 156 91.9 89.3 93.1 34.4 36.0 31.1 21.1 11.4 34.6
2 type 2 codes MUSC 316 140 176 83.7 64.7 86.6 60.8 65.7 49.0 34.2 7.9 55.1
UNC 256 133 123 82.6 82.1 82.8 59.0 63.7 49.3 27.7 17.3 39.0
1 type 2 codes and 0 type 1 codes MUSC 76 23 53 41.9 58.8 39.3 95.9 96.5 94.2 71.1 43.5 83.0
UNC 73 34 39 54.7 46.4 58.6 94.2 93.1 96.6 64.4 38.2 87.2
Ratio of type 2 codes to the sum of
type 1 and type 2 codes  0.3
MUSC 181 50 131 93.0 94.1 92.9 88.5 91.0 82.6 66.3 32.0 79.4
UNC 151 75 76 91.9 89.3 93.1 84.0 83.5 85.1 52.3 33.3 71.1
Ratio of type 2 codes to the sum of
type 1 and type 2 codes  0.4
MUSC 168 42 126 91.5 94.1 91.1 90.6 93.1 84.5 70.2 38.1 81.0
UNC 138 65 73 91.9 89.3 93.1 86.9 86.8 87.2 57.2 38.5 74.0
Ratio of type 2 codes to the sum of
type 1 and type 2 codes  0.5
MUSC 164 39 125 91.5 94.1 91.1 91.3 93.9 85.2 72.0 41.0 81.6
UNC 128 58 70 88.4 82.1 91.4 88.5 88.4 88.5 59.4 39.7 75.7
Ratio of type 2 codes to the sum of
type 1 and type 2 codes  0.6
MUSC 151 32 119 88.4 82.4 89.3 93.0 95.2 87.7 75.5 43.8 84.0
UNC 116 51 65 84.9 75.0 89.7 90.5 90.1 91.2 62.9 41.2 80.0
True diabetes cases (N¼ 660 at MUSC and N¼ 537 at UNC) confirmed by medical record review established our “gold standard” for evaluation of the algorithms’ performance.
Abbreviations: MUSC: Medical University of South Carolina; PPV: positive predictive value; UNC: University of North Carolina.
aResults from UNC were previously published.10
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presumptive cases were true negatives, which may have missed a
small number of true cases. However, among those presumptive
cases that had only 1 indicator of diabetes, the false positive rate was
about 90% or higher; the false positive rate was further increased to
95% or higher among those who had 1 indicator other than billing
codes (data not shown). Therefore, it is highly unlikely that our findings
would be biased by the false negatives that we failed to find, given the
low prevalence of diabetes in children. Finally, we ascertained and
classified prevalent cases, not incident cases. In SEARCH, natural lan-
guage processing is being evaluated to extract diagnosis dates from
medical records with the aim of identifying incident cases, which was
not in the scope of this analysis.
CONCLUSION
We used billing data and targeted manual medical record review to de-
velop a stepwise surveillance approach which efficiently and accurately
ascertained and classified prevalent diabetes cases in 2 large, indepen-
dent US public health care delivery systems. This approach relied largely
on automated algorithms and required only a small amount (<30%) of
manual validation efforts compared to traditional surveillance methods.
Further validation of the stepwise surveillance approach in other health
care systems or in the same health care system at different time points
may provide additional information before it can be widely implemented
across the United States for surveillance of childhood diabetes.
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Table 4: The performance of the stepwise surveillance approach
Diabetes
Type
MUSC UNC
Review 289 (27.4%) of
1055 records
Review 234 (18.2%) of
1289 records
Sensitivity Positive
predictive
value
Sensitivity Positive
predictive
value
Total 97.9 96.7 97.0 96.8
Type 1 99.6 93.9 99.3 94.8
Type 2 91.5 100.0 89.5 100
Othera 79.2 100 80.4 100
Abbreviations: MUSC: Medical University of South Carolina; UNC:
University of North Carolina.
aIncluded cases with diabetes other than type 1 or type 2.
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